StockSelector.com
  Research, Select, & Monitor Friday, February 22, 2019 1:07:08 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Corcept Therapeutics Inc.$11.50$.413.70%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Corcept Therapeutics Inc. has an overall rank of 5685 out of 5883 stocks based on 5 positive rankings and 7 negative rankings.

Positive Rankings
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Corcept Therapeutics Inc. is ranked 79.
Top Industry Values
Corcept Therapeutics Inc. rank is 363
PEGValue
Corcept Therapeutics Inc. has a PEG Value of $13.78. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 24.24% in the next year. Among companies with a PEG Value above the current stock price, Corcept Therapeutics Inc. is ranked 564.
Target Prices
The average analysts' target price is $12.00 for Corcept Therapeutics Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Corcept Therapeutics Inc. is ranked 584.
SSValue
The StockSelector Value for Corcept Therapeutics Inc. is $18.68. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Corcept Therapeutics Inc. is ranked 641.
Negative Rankings
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Corcept Therapeutics Inc. is ranked 28.
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (12.58%). Among companies that have had their estimates lowerec within the past month, Corcept Therapeutics Inc. is ranked 86.
Negative Guidance
Within the past 90 days Corcept Therapeutics Inc. has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
High vPut/Call
Corcept Therapeutics Inc. has a high Put/Call ratio of 2.21 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Corcept Therapeutics Inc. is ranked 517.
High Put/Call
Corcept Therapeutics Inc. has a high Put/Call ratio of 1.40 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Corcept Therapeutics Inc. is ranked 560.
10 Day Loss
Corcept Therapeutics Inc. rank is 635
90 Day Loss
Corcept Therapeutics Inc. rank is 922







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.